Rac1-Abi-1 Signaling Links DNA Repair to Tumorigenesis
The DNA damage response governs genomic integrity, and abnormal DNA repair can drive tumorigenesis. We previously identified a Rac1-Abi-1 signaling pathway in which Rac1 activates protein phosphatase 5, leading to Abi-1-S323 dephosphorylation and enhanced non-homologous end joining (NHEJ). Given the error-prone nature of NHEJ and its potential to promote genomic instability, we sought to determine whether Rac1-Abi-1-mediated regulation of NHEJ contributes to tumorigenesis. Here, we demonstrate the tumorigenic role of Abi-1-S323 dephosphorylation in nonmalignant cell models and multiple tumorigenesis models established using a newly generated genetically engineered Abi-1 mouse model. We first found that the dephospho-mimetic Abi-1-S323A mutant promoted transformation-associated phenotypes in nonmalignant human cells and enhanced orthotopic glioblastoma growth under unperturbed conditions. To further investigate its tumorigenic potential in vivo, we generated CRISPR/Cas9-mediated Abi-1-S296A knock-in mice, in which S296 corresponds to human S323. Abi-1-S296A mouse embryonic fibroblasts exhibited increased proliferation, while mutant mice developed spontaneous tumors involving lymphoid tissues and organs under unperturbed conditions. Furthermore, Abi-1-S296A increased susceptibility to tumorigenesis following DNA damage. In a low-dose whole-body irradiation model, Abi-1-S296A mice showed a trend toward shortened survival and increased tumor development, with lesions including Harderian gland papillary cystadenomas, round-cell neoplasms, and anaplastic sarcomas. In addition, in an azoxymethane/dextran sulfate sodium (AOM/DSS)-induced colorectal tumor model, Abi-1-S296A mice developed significantly more tumors and had a greater tumor burden. These findings identify Abi-1-S323 dephosphorylation as a previously unrecognized regulator of tumorigenesis and establish a new mouse model for investigating the physiological and pathological consequences of constitutive activation of upstream NHEJ-regulatory signaling.
Authors
- Thomas L. Saunders (ORCID: https://orcid.org/0000-0003-2015-101X)
- Sriram Venneti (ORCID: https://orcid.org/0000-0001-9764-0423)
- Meredith Ann Morgan (ORCID: https://orcid.org/0000-0001-7965-6878)
- Yatrik Madhukar Shah (ORCID: https://orcid.org/0000-0002-2487-4816)
- Angelica Lin (ORCID: https://orcid.org/0009-0007-6217-673X)
- Daniel Richard Wahl (ORCID: https://orcid.org/0000-0001-9894-5085)
- Zachary T. Freeman (ORCID: https://orcid.org/0000-0003-1291-382X)
- Sumeet A. Solanki (ORCID: https://orcid.org/0000-0002-2773-3082)
- Menggang Yu (ORCID: https://orcid.org/0000-0002-7904-3155)
- Weihua Zhou (ORCID: https://orcid.org/0000-0003-0259-0828)
- Yuezhong Zhang (ORCID: https://orcid.org/0000-0002-8827-0114)
- Kari Wilder-Romans (ORCID: https://orcid.org/0000-0003-1468-1508)
- Wilson Zheng (ORCID: https://orcid.org/0000-0002-8520-8569)
- Honglai Zhang (ORCID: https://orcid.org/0000-0003-3416-3783)
- Elizabeth C. McCulla (ORCID: https://orcid.org/0009-0003-2583-0094)
- Mingjia Tan
- Jihan Park
- Timothy Jho
- Theodore S. Lawrence
- Ziqing Zhu
- Yiheng Huang
- Jie Xu
- Jing Li
- Daven Kothari
- Benjamin Curtis
Institutions
- University of Michigan (US)
- Cell Signaling Technology (United States) (US)
Publication Details
- Journal
- bioRxiv (Cold Spring Harbor Laboratory)
- Published
- 2026-11-18
- DOI
- https://doi.org/10.64898/2026.11.13.766481
- Primary Topic
- DNA Repair Mechanisms
- Type
- preprint
Funders
- National Science Foundation
- National Cancer Institute